Submission Details
| 510(k) Number | K022772 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 21, 2002 |
| Decision Date | September 17, 2002 |
| Days to Decision | 27 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K022772 is an FDA 510(k) clearance for the RAICHEM LDL-CHOLESTEROL DIRECT REAGENT, a System, Test, Low Density, Lipoprotein (Class I — General Controls, product code MRR), submitted by Hemagen Diagnostics, Inc. (Columbia, US). The FDA issued a Cleared decision on September 17, 2002, 27 days after receiving the submission on August 21, 2002. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1475.
| 510(k) Number | K022772 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 21, 2002 |
| Decision Date | September 17, 2002 |
| Days to Decision | 27 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | MRR — System, Test, Low Density, Lipoprotein |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1475 |